NCT05498974

China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 20,000 (estimated)
• Sponsor: Second Xiangya Hospital of Central South University · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The aim of the China Diabetes Type 1 Study (CD1S) is to conduct a nationwide type 1 diabetes (T1D) registry study in patients with T1D and in pediatric adolescent patients with diabetes who had an age of onset \<= 20 years. CD1S compromises a retrospective study enrolling inpatients hospitalized from Jan 1st, 2016 to Dec 31, 2021, and a prospective study beginning from the year 2022.

Detailed description

The aim of the China Diabetes Type 1 Study (CD1S) is to conduct a nationwide type 1 diabetes (T1D) registry study to investigate the demographic characteristics, metabolic control, complications occurrence as well as risk factors of patients with T1D, and to investigate the clinical features, complications' burdens and risk factors in pediatric adolescent patients with diabetes who had an age of onset \<= 20 years.

Conditions

• Type1diabetes
• Diabetes

Interventions

Type	Name	Description
OTHER	Standard type 1 diabetes management model constructed by China Alliance for Type 1 Diabetes in each center	Standard type 1 diabetes management model constructed by China Alliance for Type 1 Diabetes in each center

Timeline

• Start date: 2022-01-01
• Primary completion: 2035-12-31
• Completion: 2035-12-31
• First posted: 2022-08-12
• Last updated: 2022-08-12

Locations

11 sites across 1 country: China